A two year study involving a new formulation of Rebif reported a marked increase in injection tolerability. The new formulation was approved by the European Commision in August and will be available to patients in the UK by early 2008.
Links to muliple sclerosis news stories
Oct
12
A two year study involving a new formulation of Rebif reported a marked increase in injection tolerability. The new formulation was approved by the European Commision in August and will be available to patients in the UK by early 2008.
Posted in news |